RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

2024 Annual General Meeting of Shareholders

Home  >  Investor Relations  >  Financial Reports & SEC Filings  >  Annual General Meeting  >  2024 Annual General Meeting of Shareholders

2024 Annual General Meeting of Shareholders of QIAGEN N.V.

The Annual General Meeting of Shareholders of QIAGEN N.V. ("AGM") will be held on Friday, June 21, 2024 at 10:00, local time, at Maaspoort, Oude Markt 30, 5911 HH Venlo, The Netherlands.

On May 8, 2024 the total number of shares of the Company issued is 223,904,429.41 and the number of voting rights is 221,847,134. The number of voting rights does not include the treasury shares held by the Company and the fractional shares.

A webcast of the AGM will be hosted on June 21, 2024, at 10:00 a.m. CET. Shareholders will be able to follow the meeting in listen-only mode. It will not be possible to vote or address the meeting via the webcast.

Notice of the AGM

Download item year list 2024

Proxy Statement

Proposed Amendments to the Articles of Association